title: Osteoporosis in liver cirrhosis--overview.
abstract: Osteoporosis can occur as a result of liver cirrhosis. The pathogenesis of reduced bone mineral density in liver cirrhosis is multifactorial. It can be caused by alterations in calcium and vitamin D homeostasis, as well as nutritional and dietary factors. Dual-energy X-ray absorptiometry (DXA) has become the gold standard in assessing bone mineral density in patients with liver cirrhosis. In such cases, patients can be treated with calcium and vitamin D supplements, bisphosphonates and hormonal replacement therapy (HRT).
authors.affiliation: Gastroenterology and Hepatology Institute Iaşi, "Gr.T. Popa" University of Medicine and Pharmacy, Iaşi.
authors.forename: Cristina
authors.initials: C
authors.lastname: Cijevschi
authors.forename: Cătălina
authors.initials: C
authors.lastname: Mihai
authors.forename: V L
authors.initials: VL
authors.lastname: Drug
authors.forename: E
authors.initials: E
authors.lastname: Zbranca
authors.forename: P
authors.initials: P
authors.lastname: Gogălniceanu
mesh_terms: D015519:Bone Density; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D020249:Hormone Replacement Therapy / Q000379:methods; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D004164:Diphosphonates; D014807:Vitamin D; D002118:Calcium